Christopher S. Kiper

US·SEC (Form 4)

Lifecore Biomedical, Inc. \DE\

Total declarations

Company

▲ Purchases (2 ops.)

€5.4M

▼ Sales (0 ops.)

—

Latest filing published 17 Jul 2025 for LIFECORE BIOMEDICAL, INC. \DE\.

Filing timeline

BuySale

Christopher S. Kiper

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

LIFECORE BIOMEDICAL, INC. \DE\ 1 purchase · last 07 Oct 2024

Since each purchase

Lifecore Biomedical, Inc. \DE\
Filed 07 Oct 2024 · 747 days ago · €4.9M
+42.8%
Entry US$4.81 · Close at T+365 US$6.87

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Christopher S. Kiper: trading record in brief

All filings by Christopher S. Kiper on record concern Lifecore Biomedical, Inc. \DE\. We count 7 filings; the first trade dates from 9 January 2023 and the latest from 15 July 2025.

Every open-market trade on record is a purchase: 2 purchases worth €5.4M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants.

The latest filing, published on 17 July 2025, reports a share grant in Lifecore Biomedical, Inc. \DE\. The most recent open-market purchase was published on 7 October 2024, 746 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.